Communiqués Anika Therapeutics, Inc.

Actions

ANIK

US0352551081

Equipement, fournitures et distribution médicale

Temps réel estimé Cboe BZX 20:38:11 29/09/2026			Varia. 5j.	Varia. 1 janv.
19,96 ^USD	-3,51%		-4,72%	+107,13%

18/09	Anika Therapeutics, Inc. : B. Riley toujours à l'achat	ZM
30/07	Anika Therapeutics, Inc. : Barrington Research favorable sur le dossier	ZM

Communiqués

29/07	Anika: Q2 Earnings Snapshot	AQ
29/07	Anika Reports Second Quarter 2026 Financial Results	AQ
15/07	Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026	GL
05/06	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
30/04	Anika Therapeutics : 2025 Annual Report	PU
30/04	Anika Therapeutics : 2026 Proxy Statement	PU
29/04	Anika: Q1 Earnings Snapshot	AQ
29/04	Anika Reports First Quarter 2026 Financial Results	AQ
15/04	Anika to Issue First Quarter 2026 Financial Results on Wednesday, April 29, 2026	GL
06/04	Anika Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
03/04	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
26/02	Anika: Q4 Earnings Snapshot	AQ
26/02	Anika Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
18/02	Anika To Present at the Canaccord Genuity 2026 Musculoskeletal Conference	GL
12/02	Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026	GL
08/01	Anika Therapeutics Announces Leadership Transition	GL
05/11	Anika: Q3 Earnings Snapshot	AQ
05/11	Anika Reports Third Quarter 2025 Financial Results	AQ
05/11	Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study	GL
23/10/25	Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025	GL
08/09/25	Anika Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	AQ
05/09/25	Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	GL
30/07/25	Anika: Q2 Earnings Snapshot	AQ
30/07/25	Anika Reports Second Quarter 2025 Financial Results	AQ
30/07/25	Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update	GL